Is Adagene Inc. (ADAG) a Buy, Sell, or Hold?
NASDAQ : ADAG
Adagene Inc. — Institutional Ownership
$3.75 USD
-$0.14 (-3.6%)
- Volume
- 291.7K
- Average Volume
- 259.33K
- Market Capitalization
- $141.18M
- P/E Ratio
- -7.95
- Dividend Yield
- 0.00%
- Price Target
- $10.00
- Year High
- $4.85
- Year Low
- $1.30
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.07
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-06-08 | HAN 2020 Irrevocable Trust | 9.39M | 11.20% |
| 2026-06-08 | Peter Luo | 6.24M | 7.09% |
| 2026-05-15 | WuXi PharmaTech Healthcare Fund I L.P. | 3.49M | 5.90% |
| 2026-05-07 | JANUS HENDERSON GROUP PLC | 6.67M | 10.10% |
| 2026-03-18 | Chernett Jorey | 2.39M | 5.10% |
| 2026-02-17 | General Atlantic Singapore Fund Pte. Ltd. | - | 0.00% |
| 2026-01-29 | Smith Vincent C | 5.1M | 8.70% |
| 2025-11-14 | Panacea Venture Healthcare Fund II, L.P. | 2.25M | 3.80% |
| 2025-11-14 | WuXi PharmaTech Healthcare Fund I L.P. | 4.12M | 7.00% |
| 2025-07-02 | FMR LLC | 473.95K | 0.90% |
| 2025-05-15 | WuXi PharmaTech Healthcare Fund I L.P. | 4.98M | 8.50% |
| 2025-05-12 | FIL Limited | 936.81K | 1.80% |
| 2025-02-19 | Peter Luo | 3.68M | 6.07% |
| 2025-02-19 | HAN 2020 Irrevocable Trust | 9.18M | 15.58% |
| 2025-02-14 | Panacea Venture Healthcare Fund II, L.P. | 3.04M | 5.50% |
| 2025-02-12 | FIL Limited | 4.09M | 7.80% |
| 2025-02-04 | Smith Vincent C | 3.83M | 6.90% |
| 2024-01-19 | Panacea Innovation Limited | 2.75M | 5.00% |
| 2024-01-19 | Panacea Venture Healthcare Fund II, L.P. | 2.75M | 5.00% |
| 2024-01-19 | James Huang | 2.75M | 5.00% |
| 2024-01-19 | Panacea Venture Healthcare Fund II GP Company, Ltd. | 2.75M | 5.00% |
| 2022-04-29 | Peter Luo | 11.65M | 20.80% |
| 2022-04-29 | HAN 2020 GRAT | 5.21M | 9.51% |
| 2022-02-11 | GAP (Bermuda) L.P. | 4.78M | 8.80% |
| 2022-02-11 | General Atlantic GenPar (Bermuda), L.P. | 4.78M | 8.80% |
| 2022-02-11 | General Atlantic Partners (Bermuda) EU, L.P. | 4.78M | 8.80% |
| 2022-02-11 | General Atlantic Partners (Bermuda) IV, L.P. | 4.78M | 8.80% |
| 2022-02-11 | General Atlantic Singapore Fund Pte. Ltd. | 4.78M | 8.80% |
| 2022-02-11 | General Atlantic GenPar (Lux) SCSp | 4.78M | 8.80% |
| 2022-02-11 | General Atlantic Partners (Lux) SCSp | 4.78M | 8.80% |
| 2022-02-11 | General Atlantic (Lux) S.à r.l. | 4.78M | 8.80% |
| 2022-02-11 | General Atlantic, L.P. | 4.78M | 8.80% |
| 2022-02-11 | GAP Coinvestments IV, LLC | 4.78M | 8.80% |
| 2022-02-11 | GAP Coinvestments V, LLC | 4.78M | 8.80% |
| 2022-02-11 | GAP Coinvestments CDA, L.P. | 4.78M | 8.80% |
| 2022-02-11 | General Atlantic Singapore AI Pte. Ltd. | 4.78M | 8.80% |
| 2022-02-11 | GAP Coinvestments III, LLC | 4.78M | 8.80% |
| 2022-02-11 | General Atlantic Singapore Interholdco Ltd. | 4.78M | 8.80% |
| 2022-02-09 | FMR LLC | 4.79M | 9.09% |
| 2022-02-09 | Abigail P. Johnson | 4.79M | 9.09% |
| 2022-02-09 | Peter Luo | 11.24M | 20.22% |
| 2022-02-09 | HAN 2020 GRAT | 5.21M | 9.54% |
| 2022-01-26 | JSR Limited | 5.35M | 9.81% |
| 2022-01-26 | WuXi AppTec Co., Ltd. | 5.28M | 9.67% |
| 2022-01-26 | WuXi PharmaTech Healthcare Fund I L.P. | 5.28M | 9.67% |
| 2022-01-26 | GP Healthcare Capital Co., Ltd. | 5.35M | 9.81% |
| 2021-02-19 | FIL Limited | 4.83M | 9.15% |
ADAG Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1.89 | 37.76M | $71.37M | $74.52M | $6.26M | $3.11M |
| 2024-12-31 | $1.99 | 36.02M | $71.69M | $85.19M | $18.49M | $4.99M |
| 2023-12-31 | $1.93 | 34.64M | $66.86M | $109.93M | $22.31M | -$20.76M |
| 2022-12-31 | $1.33 | 34.65M | $45.91M | $143.76M | $27.97M | -$69.88M |
| 2021-12-31 | $8.07 | 32.02M | $258.35M | $174.39M | $7.49M | $91.45M |
| 2020-12-31 | $29.99 | 28.07M | $841.69M | $75.15M | $7.98M | $774.52M |
| 2019-12-31 | $29.99 | 35.33M | $1.06B | $92.53M | $2.56M | $969.64M |
| 2018-12-31 | $29.99 | 9.7M | $291.03M | $16.06M | $2.33M | $277.31M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1.89 | 37.91M | $71.65M | $74.52M | $6.26M | $3.39M |
| 2025-06-30 | $1.95 | 37.69M | $73.5M | $62.83M | $6.85M | $17.52M |
| 2024-12-31 | $1.99 | 36.71M | $73.06M | $85.19M | $18.49M | $6.36M |
| 2024-06-30 | $3.05 | 35.12M | $107.12M | $95.67M | $20.79M | $32.24M |
| 2024-03-31 | $3.24 | 35.12M | $113.79M | $95.67M | $20.79M | $38.91M |
| 2023-12-31 | $1.93 | 35.12M | $67.78M | $109.93M | $22.31M | -$19.85M |
| 2023-09-30 | $1.53 | 35.12M | $53.73M | $109.93M | $22.31M | -$33.9M |
| 2023-06-30 | $1.48 | 32.87M | $48.65M | $128.76M | $25.24M | -$54.87M |
| 2023-03-31 | $1.45 | 32.87M | $47.66M | $128.76M | $25.24M | -$55.86M |
| 2022-12-31 | $1.33 | 34.03M | $45.09M | $143.76M | $27.97M | -$70.7M |
| 2022-09-30 | $1.28 | 34.03M | $43.55M | $143.76M | $27.97M | -$72.23M |
| 2022-06-30 | $2.07 | 34.9M | $72.1M | $168.04M | $17M | -$78.94M |